DRREDDY vs MAXHEALTH: Stock Comparison

Dr Reddys Laboratories Ltd vs Max Healthcare Institute LtdUpdated 25 Aug 26, 4:08 PM ISTNSE & company filings

Dr Reddys Laboratories Ltd is the larger company by market capitalisation. Dr Reddys Laboratories Ltd shows a lower P/E, a higher dividend yield and lower leverage, while Max Healthcare Institute Ltd shows a higher ROE, faster revenue growth and a higher ROCE. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

DRREDDY leads 5; MAXHEALTH leads 8 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

DRREDDYMAXHEALTH

Valuation lens

What price are you paying?

Market CapContext only
₹99,281 Cr
₹98,200 Cr
P/E RatioDRREDDY has the lower reading
30.94x
65.96x
P/B RatioDRREDDY has the lower reading
2.63x
8.95x
EPSDRREDDY has the higher reading
₹39.7
₹14.8
Book ValueContext only
₹460.31
₹110
Dividend YieldDRREDDY has the higher reading
0.68%
0.18%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
DRREDDY is the larger company
₹99,281 Cr vs ₹98,200 Cr
P/E Ratio
DRREDDY has a lower P/E
30.94x vs 65.96x
P/B Ratio
DRREDDY has a lower P/B
2.63x vs 8.95x
EPS
DRREDDY has higher earnings per share
₹39.7 vs ₹14.8
Dividend Yield
DRREDDY has a higher dividend yield
0.68% vs 0.18%
Revenue Growth (TTM YoY)
MAXHEALTH has faster revenue growth
12.2% vs -11.6%
EPS Growth (TTM YoY)
MAXHEALTH has faster EPS growth
7.3% vs -86.2%
Qtr Sales Growth
MAXHEALTH has stronger quarterly sales growth
12.2% vs -11.5%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricDRREDDYMAXHEALTH
SectorHealthcareHealthcare
IndustryPharmaceuticalsHospital

Price

MetricDRREDDYMAXHEALTH
Live Price₹1,193.5₹1,016
Day Change0.29%2.57%
Volume15.7 L18.9 L
52-Week High₹1,414.9₹1,252.5
52-Week Low₹1,101₹903
Distance from 52W High-15.65%-18.88%

Valuation

MetricDRREDDYMAXHEALTH
Market Cap₹99,281 Cr₹98,200 Cr
P/E Ratio30.94x65.96x
P/B Ratio2.63x8.95x
EPS₹39.7₹14.8
Book Value₹460.31₹110
Dividend Yield0.68%0.18%

Growth

MetricDRREDDYMAXHEALTH
Revenue Growth (TTM YoY)-11.6%12.2%
EPS Growth (TTM YoY)-86.2%7.3%
Qtr Sales Growth-11.5%12.2%
Qtr Profit Growth-86.1%7.28%

Profitability & Leverage

MetricDRREDDYMAXHEALTH
ROE11.2%14.7%
ROCE13%14.7%
Net Margin12.76%17.23%
Operating Margin19.2%26.8%
Debt to Equity0.2x0.32x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricDRREDDYMAXHEALTH
Promoter Holding26.64% 0.01 pp23.71%
FII Holding32.07% 1.01 pp41.78% 3.61 pp
DII Holding31.74% 1.02 pp29.96% 3.64 pp
Public Holding9.35% 0.02 pp4.56% 0.01 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Dr Reddys Laboratories Ltd and Max Healthcare Institute Ltd.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.